Procurement of diagnostics
The WHO procurement service for diagnostics was established in 1990 to facilitate Member States' access to high quality HIV test kits at a reasonable cost. Over the years, the service has expanded to include diagnostics for HIV/AIDS, malaria, hepatitis B and hepatitis C, as well as basic laboratory consumables and equipment.
About the WHO procurement service
The Diagnostics and Laboratory Technology team works together with the Contracting and Procurement Services team to ensure the availability of quality diagnostics at reduced costs. In 2007, the service achieved:
- procurement of test kits for 45 Member States, the majority in low-income economies
- expansion of the market for HIV and malaria rapid tests
- procurement of 13 million test kits for priority diseases
- substantial savings for member states
WebBuy, an electronic procurement system is available on the WHO intranet for easy, streamlined purchasing. Access to WebBuy is available for staff at WHO headquarters and regional and country offices.
Information for manufacturers
WHO procurement focuses on diagnostics for priority diseases such as HIV, malaria, hepatitis B and hepatitis C. In order for a diagnostic test kit to become eligible to tender for WHO procurement, it must first successfully pass through prequalification and meet specific procurement criteria. Tenders, by invitation only, occur on an annual basis.
For procurement questions
Contact: Contracting and Procurement Services (WHO/CPS) email:email@example.com
Procurement guidance for countries
- Selecting and purchasing HIV, HBsAg and HCV diagnostics
Manual for procurement of diagnostics and related laboratory items and equipment
Procurement information and statistics
- Complaints and Product Alerts
- HIV Procurement
- HCV Procurement
- HBsAg Procurement
- CD4+ Technology Procurement
- Viral Load Procurement
- Equipment Consumables Procurement
Circonstances et modalités d’utilisation des tests d’infection récente pour estimer l’incidence de l’infection à HIV au niveau d’une population.
When and how to use assays for recent infection to estimate HIV incidence at a population level
HIV Rapid Assays: Operational Characteristics Report 16
- View all documents
- WHO Prequalification of Medicines, Diagnostics and Vaccines: 6th Consultative Meeting with Stakeholders, 4-5 April 2011
- WHO Technical Working Group Meeting on CD 4 Technologies,17 -19 November 2009
- WHO Technical Working Group Meeting on Prequalification of HIV Virological Technologies, 21-23 September 2009
- View all events